Imagine a video chat service to connect you with a random lawyer for $49 for 10 minutes of their time. They wouldn't have the time to truly understand you and your situation. Because it's random, you can't have an ongoing conversation with the same lawyer. They could only give generic, simple advice for a small subset of very simple problems.
Now imagine your own personal lawyer who says to you, "I rarely ever need to see you in my office. Let's just email, share documents and photos, and talk on the phone when we need to." Since you have an ongoing relationship with them and you communicate effectively and conveniently over time, they can be highly effective, helpful experts. Instead of a random doctor who can't establish a relationship with you, Sherpaa is your own personal doctor you'll interact with over time.
There are three main differences between Sherpaa and these video visit services: capability, usage, and strategy.
- Sherpaa treats ~1,500 diagnoses and the Teladocs treat ~30
- 50-90% of employees use Sherpaa, ~3% use the Teladocs
- Sherpaa isn't a bundled add-on, we're a real standalone strategy
Without the ability to manage issues with the same patient over time, no doctor would take a risk on treating a moderate or complex issue and jeopardize their medical license and malpractice policy. Patients always work with the same Sherpaa doctors over time. And Sherpaa doctors can order tests to confirm suspicions. That means Sherpaa doctors can treat ~1,500 diagnoses, TelaDoc and the others can treat ~30. Because Sherpaa doctors can confirm diagnoses with tests, arrange care with local specialists, and communicate with patients over time, we can treat and manage far more diagnoses, on par with a traditional primary care doctor. Because Teladoc and the others are simply a 10 minute phone call with a random doctor who can't order tests or follow-up and manage things over time, this restricts them to ~30 diagnoses, like pink eye and colds. These moderate and complex issues are what drive real costs for companies and employees. Fifty percent of your people will spend 5% of your costs, 40% will spend 35% of costs, and 10% will spend 65% of costs. Teladoc targets the 50% of people who spend 3% (pink eye, colds, UTIs). And Sherpaa manages the health of the 50% of people who spend 97% of costs, while also solving the simple problems for the 50% who spend next to nothing. Sherpaa manages issues like asthma, migraines, breast cancer, depression, Lyme Disease, etc.. These are the expensive things that drive real costs.
Sherpaa's usage (employees who create two or more cases a year) is typically 50% to 90%. Deconstructing Teladoc's recent IPO, Teladoc's usage is ~3%. Low usage stems from low capability.
Sherpaa is a standalone, unbundled strategy
Engagement and usage is the first step in seeing real value. That's why we invest so heavily in communicating Sherpaa's service and value to your people. TelaDoc and the others are typically bundled add-ons to your health insurance plan or your HR system. Sherpaa is a standalone strategy and we take our usage seriously. Without exceptional usage within your company, we can't prove value.